QuickMIC-A more rapid antibiotic resistance test
| Reference number | |
| Coordinator | GRADIENTECH AB |
| Funding from Vinnova | SEK 4 762 600 |
| Project duration | December 2014 - January 2017 |
| Status | Completed |
Purpose and goal
The aim of the project was to go from the early results that showed the potential of the diagnostic method, to develop an instrument prototype that automatically generates rapid antibiotic susceptibility results from clinical blood samples. In parallel, the aim has been to verify the need and the economic advantage of implementing the method for the end-user. This was done by a detailed health economics study and by a large number of visits to hospitals distributed throughout Europe. Project objectives have been met, and we now strongly focus on the further development of the IVD system.
Expected results and effects
Gradientech has together with its project partners succeeded in closing the instrument pre-study of the IVD system development - this means that we by now have instrument prototypes automatically generating AST data from clinical blood samples. Through the project we have built a close network of European hospitals and their clinical microbiology laboratories that continuously provide us with end-user input in the on-going IVD system development.
Planned approach and implementation
Gradientech has during the instrument feasibility study worked closely with an external instrument developer specialized in medical devices and IVD development. This work has included that the project manager for the instrument development at Gradientech has worked on site with our development partner at regular intervals. We have had very close contact with our project partners during the project (research group and hospital clinical laboratory), and today several employees have a joined employment at both the research group as well as at Gradientech.